The effect of RAS blockers on the clinical characteristics of COVID-19 patients with hypertension

Abstract

We observed there was no obvious difference in clinical characteristics between RAS blockers and non-RAS blockers groups. These data suggest ACEIs/ARBs may have few effects on increasing the clinical severe conditions of COVID-19.